Dr. Lal Pathlabs Ltd (NSE: LALPATHLAB, BSE: 539524) is a Gurugram, Haryana-based company in the Healthcare Referral Services industry. With a market capitalisation of ₹31,111 Cr, it ranks #276 by market cap among the 6,137 Indian listed companies on FinBizNet. At ₹1,838.20 (as of 25 Oct 2026), the share price is 9.8% below its 52-week high of ₹2,038.60 and 44.4% above its 52-week low of ₹1,272.60. The share price is up 16.5% over one year and up 4.5% over three months.
| Current Price | ₹1,838.20 |
|---|---|
| Market Cap | ₹31,111 Cr |
| NSE Symbol | LALPATHLAB |
| BSE Code | 539524 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Healthcare Referral Services |
| P/E Ratio | 61 |
| Return on Equity | 21.48% |
| Return on Assets | 13.34% |
| 52-Week Range | ₹1,272.60 – ₹2,038.60 |
| 1-Year Price Change | +16.5% |
| 3-Month Price Change | +4.5% |
| Beta (1Y) | 0.61 |
| Dividend Yield | 1.09% |
| Headquarters | Gurugram, Haryana |
| Website | www.lalpathlabs.com |
| Revenue | ₹798 Cr |
|---|---|
| Net Profit | ₹171 Cr |
| Net Margin | 21.4% |
| EPS (Basic) | ₹10.15 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
1. Running Laboratories-This segment engages in running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations.
1. Running Laboratories-100%
Dr. Lal Pathlabs Ltd is trading at ₹1,838.20, with a market capitalisation of ₹31,111 Cr.
Dr. Lal Pathlabs Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Healthcare Referral Services).
Dr. Lal Pathlabs Ltd has a P/E of 61 and a return on equity of 21.48%.
Dr. Lal Pathlabs Ltd is listed on the NSE under the symbol LALPATHLAB and on the BSE under the scrip code 539524.
Dr. Lal Pathlabs Ltd's share price is up 16.5% over one year and up 4.5% over three months. Its 52-week range is ₹1,272.60 to ₹2,038.60.
In Q1 FY27, Dr. Lal Pathlabs Ltd reported revenue of ₹798 Cr and net profit of ₹171 Cr, with basic EPS of ₹10.15 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.